Biotech

Can your early-stage business create so-called “strategic partnerships” to further develop business ideas? It's a common practice in technology and biotechnology businesses, but legal steps are needed to provide protection, notes columnist and attorney Joe Boucher. In this edtion of Early Stage, he spells out...

EraGen BioSciences has named diagnostics industry executive L. Miguel Blanc as its vice president of corporate development. Blanc, a director of the Wisconsin Biotechnology & Medical Device Association, is expected to play a significant role in the execution of the company's growth strategy during the...

A Wisconsin biotechnology company has not only landed two scientific advisors from outside the state, but outside the national as well. GenTel BioSciences, a protein chip maker based in Madison, has recruited South African scientists Reinhard Hiller and Jonathan Blackburn to serve on its Scientific...

Who says Republicans and Democrats can't work together? Well, most people who pay close attention to politics say that, actually, but there are exceptions to the rule. In this edition of Inside Wisconsin, columnist Tom Still offers kudos to the Wisconsin congressional delegation for pulling...

Platypus Technologies of Madison will use a $600,000 federal grant to develop more effective hepatitis screening assays, or tests, for researchers. The life sciences nanotech company now has raised more than $15 million in federal funding, and has begun to commercialize some of the “nano-based”...

A major funding commitment by three outside venture capital funds has placed Madison's OpGen, Inc. in a position to “revolutionize the way microbiology labs work” and address an unmet healthcare need, according to Mason Wells's Trevor D'Souza. The new investors, CHL Medical Partners, Highland Capital...

Dan Broderick, late of Broadwell Ventures, has joined the St. Louis-based venture capital firm Prolog Ventures, but he's not characterizing Missouri's gain as Wisconsin's loss. Broderick and Brian Clevinger, founder and managing director of Prolog, both say his connections could still have very beneficial impacts...